<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04569955</url>
  </required_header>
  <id_info>
    <org_study_id>FMASU R61/2020</org_study_id>
    <nct_id>NCT04569955</nct_id>
  </id_info>
  <brief_title>Knowledge and Perception of Clinical Trial Participation in Breast Cancer Patients in Egypt</brief_title>
  <official_title>Knowledge and Perception of Clinical Trial Participation in Breast Cancer Female Patients in Egypt, a Cross Sectional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Clinical trials are essential to translate new therapy concepts or rather any&#xD;
           intervention into the medical routine. Beside the well designed trial protocol, the&#xD;
           success of clinical trials depends on patient recruitment and participation.&#xD;
&#xD;
        -  This study aims to get a current picture of the patients' knowledge and perception of&#xD;
           clinical trial participation in Breast cancer female patients in Egypt, as an example to&#xD;
           Low/Middle income countries.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 20, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage of breast cancer patients who accept to participate in clinical trials</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The barriers for participation in clinical trials</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Clinical Trials</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Knowledge and perception of clinical trial participation</intervention_name>
    <description>This study aims to get a current picture of the patients' knowledge and perception of clinical trial participation in Breast cancer female patients in Egypt, as an example to Low/Middle income countries</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -Egyptian female Breast cancer patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female breast cancer patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who refuse participation&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hagar Elghazawy</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain shams university, faculty of medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hagar Elghazawy, MD</last_name>
    <phone>01006232406</phone>
    <email>dr.hagar.elghazawy@med.asu.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ain shams university, faculty of medicine</name>
      <address>
        <city>Cairo</city>
        <state>Select</state>
        <zip>1667</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hagar Elghazawy, MD</last_name>
      <phone>01006232406</phone>
      <email>hagaribrahim1@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>July 7, 2020</study_first_submitted>
  <study_first_submitted_qc>September 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2020</study_first_posted>
  <last_update_submitted>September 28, 2020</last_update_submitted>
  <last_update_submitted_qc>September 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Hagar Elghazawy</investigator_full_name>
    <investigator_title>Lecturer of clinical oncology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

